Address

Technology Development and Commercialization
University Health Network
101 College Street - Suite 150
Heritage Building - MaRS Centre
Toronto, Ontario
M5G 1L7 Canada

Staff

• Appointed in June 2006 as Director of consolidated UHN business development activities
• Joined UHN in 2004 as the Vice President, Global Ventures for the UHN Development Corporation
• Previously served as Vice President of Mojave Therapeutics (2002-2003) and Assistant VP of Immunology at Aventis Pasteur (1998-2002)
• A Professor in the Department of Immunology, Faculty of Medicine at University of Toronto for more than 20 years
• Former member of the Advisory Boards of Vengrowth Life Sciences Fund and the Institute of Biological Sciences at the National Research Council of Canada
• Recently served on the Board of Directors of Inimex Pharmaceuticals and Trillium Therapeutics
• PhD (Medical Biophysics), University of Toronto
  

T: 416-581-7410
F: 416-977-4765

• Joined UHN in July 2007 as Deputy Director & Legal Counsel
• Prior to joining UHN, provided specialized consulting and legal services to  biotechnology/medical device “start-up” companies (2005-2007)
• Previously served as (Senior) Vice President (Intellectual Property) of MDS Proteomics Inc. (2000-2004),  Patent Counsel of Aventis Pasteur (1999-2000), and as an Associate Lawyer  at McCarthy Tetrault (1998-1999)
• Over a dozen years scientific research experience
• PhD (Biochemistry) McMaster University, JD (Laws) University of Toronto
• Licensed to practice law in Ontario (Canada)
• Registered Patent Agent (Canada & US)
• Member of: Canadian Bar Association (CBA), Intellectual Property Institute of Canada (IPIC), American Intellectual Property Law Association (AIPLA), Licensing Executive Society (LES), Association of University Technology Managers (AUTM)

T: 416-581-7813
F: 416-977-4765

• Joined the TDC in January 1999 where his areas of concentration include spin-out company development,  therapeutics development, oncology and diseases of the developing world.
• Prior to UHN, he created the research business development function at the Clarke Institute of Psychiatry (now part of the Centre for Addiction and Mental Health).
• MSc, University of Toronto
• Certified Licensing Professional
• Founding Chair/Co-Chair, Ontario Society for Excellence in Technology Transfer (OnSETT) 2004-2006
• Member of AUTM and LES

T: 416-581-7403
F: 416-977-4765

• Mark joined UHN TDC in February 2008 with a background in engineering and entrepreneurship and a focus on medical devices.
• Prior to joining UHN, he has had the real-life experiences of getting start-ups up off the ground as both CEO and consultant.
• His experiences include developing strategic business and go-to market plans, transferring technology from research institutions, raising funds, developing product, managing large technical programs, and achieving first major sales to pharma and biotech companies.
• BASc (Toronto, Engineering Science), M.Sc. (Virginia Tech), MBA (Rotman)
• Member of Professional Engineers Ontario (P.Eng)

T: 416-581-7404
F: 416-977-4765

• Joined UHN TDC in March 2007
• Prior to joining UHN, he was the President and CEO of R1 Biotech Advisors and the Director of Biosciences at Davarcci Associates
• He was Senior Associate Director of Business Development in a US biotechnology company and has additional experience in Regulatory Affairs, Intellectual Property, and Risk Assessment/Management
• He also served as a Senior Projects Manager and a Special Expert Advisor at US NCI/NIH
• Ph.D. (Microbiology and Immunology), The University of Western Ontario and MBA, University of Toronto

T: 416-581-7728
F: 416-977-4765

Business Development Officer

• Joined the TDC in November 2004
• Prior to joining UHN, she was an Investment Analyst for MedInnova Partners Inc. and University Medical Discoveries Inc., both early-stage venture capital companies affiliated with MDS Capital Corp.
• Worked as a Research Assistant at the Terry Fox Cancer Research Laboratory, Memorial University
• She also has experience as a Technology Commercialization Officer for Genesis Group Inc.; the technology transfer arm of Memorial University
• MSc in Medicine, Memorial University and MBA, Memorial University

T: 416-581-7405
F: 416-977-4765

• Joined TDC in November 2006
• Prior to coming to UHN, he trained in the Intellectual Property department of a major Toronto law firm focusing on biotechnology and pharmaceutical patents and worked as an IP liaison officer at Cancer Care Ontario
• Directed research departments of biotechnology companies in Canada and Germany
• PhD, Molecular Biology and Genetics, University of Konstanz, Germany
• Member of AUTM
  

T: 416-581-7832
F: 416-977-4765

• Joined TDC in August 2002
• Coordinates all agreements for the TDC office and maintains the UHN Intellectual Property database
• Cheryl has completed the AUTM course in Technology Operations and Organization Licensing
• MA, University of Toronto
  
  
  
  

T: 416-581-7400
F: 416-977-4765